Phcog.Net logo

BROWSE ALL JOURNALS

    SEE ALL 6 JOURNALS
    Phcog.Net JOURNAL OF PHARMACOLOGY AND PHARMACOTHERAPEUTICS Volume 14 · Issue 3 2023 · pp. 169–248
    Search this issue

    Cover: Journal of Pharmacology and Pharmacotherapeutics

    Journal of Pharmacology and Pharmacotherapeutics

    Volume 14, Issue 3

    2023 · pp. 169–248 · 10 articles

    Volume
    14
    Issue
    3
    Published
    2023
    Pages
    169–248
    Articles
    10
    Sections
    4
    ISSN
    ISSN: Print - 0976-500X, Online - 0976-5018
    Journal
    J Pharmacol. Pharmacother.

    In this issue

    Editorial

    1. Forum Article

      A Glimpse into the Diverse Horizons of Pharmacological Research: Insights From the Latest Issue

      Mueen Ahmed

      pp. 169–170 · DOI: 10.1177/0976500X231221181 · Published 2023

    Review Article

    1. Review

      Perspectives of ChatGPT in Pharmacology Education, and Research in Health Care: A Narrative Review

      Chetna R. Patel, Sajal K. Pandya, Brijesh M. Sojitra

      pp. 171–177 · DOI: 10.1177/0976500X231210427 · Published 2023

      In the era of advanced Open artificial intelligence (AI) technology, the large language model tool known as chat generative pre-training transformer (ChatGPT) is gaining an increasing number of users in various fields su

    2. Review

      Various Factors Influencing the Enantiomers of Warfarin Pharmacokinetics: A Systematic Review of Population Pharmacokinetics

      Sirajudeen Mahaboob, G.N.K. Ganesh, K.P. Arun, S.D. Rajendran

      pp. 178–186 · DOI: 10.1177/0976500X231211401 · Published 2023

      Warfarin is the most commonly prescribed anti-coagulant medication. Warfarin’s pharmacokinetics (PK) in its enantiomeric form have been reported to be highly variable. Five population pharmacokinetic model studies for wa

    Research Article

    1. Article

      Moringa oleifera Modulates MPTP-induced Mitochondrial Dysfunction in Parkinson’s Mouse Model: An in silico and in vivo Analysis

      Smriti Singh, Priyanka Kumari Keshri, Vijaya Nath Mishra, Surya Pratap Singh

      pp. 187–200 · DOI: 10.1177/0976500X231220085 · Published 2023

      Background: Parkinson’s disease (PD) is a movement-affecting neurodegenerative condition with an unclear etiology. Recent research suggests targeting poly-(adenosine 5-diphosphate-ribose) polymerase 1 (PARP1) as a potent

    2. Article

      A Study to Evaluate the Efficacy of Saroglitazar in Non-Alcoholic Steatohepatitis Induced by High Fructose Diet Rat Model

      Saravanan T., Shanmugapriya S., Eliz Thomas, Karthika P.

      pp. 201–209 · DOI: 10.1177/0976500X231213486 · Published 2023

      Background: Non-alcoholic steatohepatitis (NASH) is a clinical condition with a global prevalence of 25.24%. Peroxisome proliferator-activated receptors (PPAR) have been significantly associated with the pathogenesis of

    3. Article

      Anti-rheumatic and Memory-enhancing Effect of Memantine on Complete Freund’s Adjuvant-induced Rheumatoid Arthritis Compared to Methotrexate in Wistar Rats

      Sharmila V. Jalgaonkar, Sumith Ourasang, Raakhi K. Tripathi, Pradeep Vaideeswar, Padma Badhe

      pp. 210–219 · DOI: 10.1177/0976500X231211394 · Published 2023

      Objectives: To evaluate the anti-inflammatory and memory-enhancing effects of memantine (MEM) in complete Freund’s adjuvant (CFA)-induced rheumatoid arthritis (RA) in Wistar rats. The effect of MEM on cognition in CFA-in

    4. Article

      Cost-effectiveness and Side Effects of Using Heparin and Enoxaparin as a Treatment for COVID-19-associated Coagulopathy

      Nurul Iska Ulmarika Idris, Abdul Khairul Rizki Purba, Arifa Mustika, Anna Surgean Veterini, Mochamad Yusuf Alsagaff, Mohammad Qorib

      pp. 220–230 · DOI: 10.1177/0976500X231217140 · Published 2023

      Objective: To analyze the cost-effectiveness and side effects of Heparin and Enoxaparin anti-coagulant in patients with COVID-19-associated coagulopathy (CAC). Materials and Methods: This was an observational study with

    5. Article

      Effect of Fluoxetine and Escitalopram on Heart Rate Variability (HRV) and Serum Potassium Level in Patients of Depression and Anxiety Disorders

      Truptiben R Machhi, Chetna R. Patel, Sajal K. Pandya, N. D. Kantharia

      pp. 231–237 · DOI: 10.1177/0976500X231213153 · Published 2023

      Background: The present study was conducted to generate data regarding the effect of fluoxetine as an anti-depressant and escitalopram as an antianxiety agent on heart rate variability (HRV). There is a scarcity of data

    6. Article

      Aristolochia bracteolata Lam.’s Toxicity Profile and Neuroprotective Effects in Mice with Memory Impairment Triggered by Scopolamine

      Dhivya P. Sundaram, Swathy Govindaswamy, Sridevi Sangeetha K. S., Palanisamy Selvamani, Subbiah Latha

      pp. 238–245 · DOI: 10.1177/0976500X231215933 · Published 2023

      Aim: The present study aims to investigate the toxicity profile and neuroprotective effect of ethanol crude extract of Aristolochia bracteolata (EEAB) leaves in mice. Materials and Methods: EEAB was subjected to prelimin

    Case Report

    1. Article

      Terbinafine-induced Myositis: A Case Report

      Atiqulla Shariff, Vaishakhi Shetty, Muskan Singh, Anjani Kumari, Sathvik Belagodu Sridhar, Srikanth Malavalli Siddalingegowda

      pp. 246–248 · DOI: 10.1177/0976500X231214031 · Published 2023

      We report a case of terbinafine-induced myositis in a 37-year-old Asian male patient treated for Tinea cruris. The patient complained of severe generalized body aches, weakness, fever, fatigue, and passing of concentrate